Stockreport

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

Entero Therapeutics Inc.  (ENTO) 
PDF BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company sp [Read more]